Clinical Trial Update: Evaluation of Amniotic Fluid Product in Knee Osteoarthritis [NA]

View source ↗

Summary

MiMedx Group, Inc. reports that its clinical trial evaluating an amniotic fluid product for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Amniotic Fluid Product

Snippet

Sponsor: MiMedx Group, Inc. | Conditions: Osteoarthritis of the Knee | NA | Status: COMPLETED